Higher susceptibility to infection and diagnostic uncertainty in elderly patients can lead to increased levels of antibiotic exposure, limiting antibiotic effectiveness and resulting in antibiotic resistance.
Increased length of stay
Higher hospital mortality
Increased hospital costs
Increased length of stay
Higher hospital mortality
Increased hospital costs
Procalcitonin (PCT) testing has been demonstrated to aid in decreasing diagnostic uncertainty and can improve antibiotic decision making, facilitating effective antibiotic stewardship (ABS). This can lead to reduced unnecessary antibiotic exposure in all patients, including those over the age of 75.
PCT testing can allow physicians to gain more timely information, even in elderly patients with atypical presentation of symptoms